detalle del documento
IDENTIFICACIÓN

doi:10.1007/s10072-024-07508-6...

Autor
Kubat, Gokhan Burcin Picone, Pasquale
Langue
en
Editor

Springer

Categoría

Medicine & Public Health

Año

2024

fecha de cotización

1/5/2024

Palabras clave
amyotrophic lateral sclerosis mitochondria skeletal muscle dysfunction mitochondrial transplantation mitochondrial therapeutic cells
Métrico

Resumen

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neuromuscular disease that results in the loss of motor neurons and severe skeletal muscle atrophy.

The etiology of ALS is linked to skeletal muscle, which can activate a retrograde signaling cascade that destroys motor neurons.

This is why satellite cells and mitochondria play a crucial role in the health and performance of skeletal muscles.

This review presents current knowledge on the involvement of mitochondrial dysfunction, skeletal muscle atrophy, muscle satellite cells, and neuromuscular junction (NMJ) in ALS.

It also discusses current therapeutic strategies, including exercise, drugs, stem cells, gene therapy, and the prospective use of mitochondrial transplantation as a viable therapeutic strategy.

Kubat, Gokhan Burcin,Picone, Pasquale, 2024, Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches, Springer

Documento

Abrir

Compartir

Fuente

Artículos recomendados por ES/IODE IA

Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
agphd1 subtypes replication hykk squamous cell gene carcinoma causal targets mendelian randomization cancer analysis